These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3213288)

  • 1. Proliferation of invasive breast carcinomas and colorectal adenocarcinomas: an immunohistochemical in situ investigation with the monoclonal antibody Ki-67.
    Horny HP; Horst HA
    Zentralbl Allg Pathol; 1988; 134(6):547-54. PubMed ID: 3213288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables.
    Lanza G; Cavazzini L; Borghi L; Ferretti S; Buccoliero F; Rubbini M
    Pathol Res Pract; 1990 Oct; 186(5):608-18. PubMed ID: 2287588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
    He Q; Mao Y; Wu J; Decker C; Merza M; Wang N; Eriksson S; Castro J; Skog S
    Int J Oncol; 2004 Oct; 25(4):945-53. PubMed ID: 15375544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
    Weikel W; Beck T; Rosenthal H; Herzog R
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [P53 protein in adenocarcinoma of the large intestine].
    Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.
    Shepherd NA; Richman PI; England J
    J Pathol; 1988 Jul; 155(3):213-9. PubMed ID: 3411382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of proliferative markers ki-67 and repp86 in breast cancer.
    Mohsenifar J; Almassi-Aghdam M; Mohammad-Taheri Z; Zare K; Jafari B; Atri M; Mortazavi SH; Azadeh P; Bagherzadeh M; Azargashb E; Rahimi F
    Arch Iran Med; 2007 Jan; 10(1):27-31. PubMed ID: 17198450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in proliferation markers in colorectal cancer.
    Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
    Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
    Lellé RJ
    Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
    Nabi U; Nagi AH; Sami W
    J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
    Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
    Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
    Kocová L; Skálová A; Fakan F; Rousarová M
    Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.